πŸ₯ VAERS Vaccine Data Browser

πŸ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

πŸ“– Help & Search Guide

Column Icons Legend

πŸ’€ Death
πŸ₯ Hospitalized
πŸš‘ Emergency Room
β™Ώ Disability
⚠️ Life Threatening

How to Search

πŸ’‘ Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "πŸ“₯ Export CSV" to download filtered data (max 10,000 records)

πŸ’‘ Frequently Asked Questions (FAQ)

What is this site?

πŸ₯ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • βœ… Early warning system for potential safety signals
  • βœ… Open and transparent - publicly accessible
  • βœ… Accepts all reports regardless of likelihood of causation
  • βœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
πŸ”„ Reset πŸ“₯ Export CSV
ID Age Sex State Date β–Ό Onset Days Vaccine Manufacturer Lot # Symptoms Narrative πŸ’€ πŸ₯ πŸš‘ β™Ώ ⚠️
2850300 70 F FL 07/18/2025 RSV
PFIZER\WYETH
md5462
Injection site bruising, Injection site erythema, Injection site pain, Injection... Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling More
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injec... Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium More
2850301 58 F NJ 07/18/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
55th4
Injection site erythema, Injection site pain, Injection site swelling Injection site erythema, Injection site pain, Injection site swelling
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injec... Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium More
2850302 58 F CT 07/18/2025 PNC21
MERCK & CO. INC.
z004301
Injection site erythema, Injection site pain, Injection site pruritus, Injection... Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Pyrexia More
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Inject... Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Fever-Medium, Other Vaccines: VaccineTypeBrand: heplisav; Manufacturer: dynavax tech; LotNumber: 946064; Route: im; BodySite: left deltoid; Dose: 1; VaxDate: 06/28/2025 More
2850304 64 M SC 07/18/2025 TDAP
GLAXOSMITHKLINE BIOLOGICALS
h4279
Dizziness Dizziness
Systemic: Dizziness / Lightheadness-Mild, Additional Details: patient states that he felt like he wa... Systemic: Dizziness / Lightheadness-Mild, Additional Details: patient states that he felt like he was going to pass out. More
2850305 53 F NE 07/18/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
TS525
Injection site erythema, Injection site pain Injection site erythema, Injection site pain
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium
2850307 65 F FL 07/18/2025 PNC20
PFIZER\WYETH
ln4928
Injection site bruising, Injection site erythema, Injection site pain, Injection... Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling More
Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection... Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild More
2850308 28 F MA 07/18/2025 TDAP
GLAXOSMITHKLINE BIOLOGICALS
h4279
Joint injury Joint injury
Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)- Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
2850309 70 M FL 07/18/2025 COVID19
PFIZER\BIONTECH
me6072
Asthenia, Hypoaesthesia, Injection site bruising, Injection site erythema, Parae... Asthenia, Hypoaesthesia, Injection site bruising, Injection site erythema, Paraesthesia More
Site: Bruising at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: arm/finge... Site: Bruising at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: arm/finger numbness/tingling especially in wrist-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Weakness-Medium, Additional Details: numbness/tingling arm/hand/wrist More
2850310 55 F CA 07/18/2025 PNC21
MERCK & CO. INC.
z003579
Heart rate increased, Injection site erythema, Injection site pain, Palpitations Heart rate increased, Injection site erythema, Injection site pain, Palpitations
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: fast heart be... Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: fast heart beat/ palpitations-Mild, Other Vaccines: VaccineTypeBrand: boostrix; Manufacturer: glaxosmithkline; LotNumber: h4279; Route: im; BodySite: right deltoid; Dose: 1; VaxDate: UNKNOWN More
2850311 29 M TX 07/18/2025 HEP
HEP
DYNAVAX TECHNOLOGIES CORPORATION
DYNAVAX TECHNOLOGIES CORPORATION
946064
946064
Chest discomfort, Chest pain, Eye swelling, Mouth swelling, Pruritus; Swelling f... Chest discomfort, Chest pain, Eye swelling, Mouth swelling, Pruritus; Swelling face, Swollen tongue More
Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / T... Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Additional Details: pt developed symptoms 15 min after injection, he rushed to ER and was given benadryl and medrol dose pack. Symptoms has subside after medication More
2850312 50 M GA 07/18/2025 VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
5Y4TL
5Y4TL
Dizziness, Flushing, Hyperhidrosis, Injection site pain, Loss of consciousness; ... Dizziness, Flushing, Hyperhidrosis, Injection site pain, Loss of consciousness; Pallor, Syncope, Tremor, Unresponsive to stimuli More
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Un... Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild, Additional Details: AFTER VACCINE ADMNISTRATION, PATIENT BECAME LIGHT HEADED DIZZY, PASSED OUT 5-10 SECONDS, SHAKING, THEN BECAME ALERT. THEN, SWEATY, FLUSH, PALE. NO FALLS, BLOOD PRESSUE ~10 MINS AFTER EVEN 104/72 PULSE 80, ~25 MINS AFTER 124/80 More
2850313 42 M CA 07/18/2025 TDAP
TDAP
TDAP
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
h4279
h4279
h4279
Chills, Dizziness, Fatigue, Hypoaesthesia, Hypotension; Injection site erythema,... Chills, Dizziness, Fatigue, Hypoaesthesia, Hypotension; Injection site erythema, Injection site pain, Injection site swelling, Lethargy, Pain; Pyrexia, Tremor, Vomiting More
Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injec... Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Severe, Systemic: Hypotension-Medium, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Shakiness-Medium, Systemic: Vomiting-Mild More
2850315 65 F TX 07/18/2025 RSV
RSV
PFIZER\WYETH
PFIZER\WYETH
lm2215
lm2215
Asthenia, Fatigue, Injection site pain, Lethargy, Pain; Pyrexia Asthenia, Fatigue, Injection site pain, Lethargy, Pain; Pyrexia
Site: Pain at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion /... Site: Pain at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Severe, Systemic: Weakness-Severe, Additional Details: pt came after a month complaining she has take pain management course probably some kind of injection and was in mergency for few days, Other Vaccines: VaccineTypeBrand: shingles; Manufacturer: glaxosmith; LotNumber: 3273h; Route: im; BodySite: left; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: covid; Manufacturer: pfizer; LotNumber: md3414; Route: im; BodySite: right; Dose: ; VaxDate: UNKNOWN More
2850316 72 F NJ 07/18/2025 COVID19
PFIZER\BIONTECH
ME6072
Epistaxis, Headache, Injection site erythema, Injection site pain Epistaxis, Headache, Injection site erythema, Injection site pain
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Reported bloody n... Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Reported bloody nose-Medium, Systemic: Headache-Medium, Additional Details: Patient came to pharmacy in-person on 07/08/25 and reported that she had these side effects after receiving the vaccine on 06/24/25. More
2850317 77 F CA 07/18/2025 MMR
GLAXOSMITHKLINE BIOLOGICALS
a2b72
No adverse event No adverse event
Site: Redness at Injection Site-Mild, Systemic: Weakness-Mild, Additional Details: pt is on radiatio... Site: Redness at Injection Site-Mild, Systemic: Weakness-Mild, Additional Details: pt is on radiation told the pharmacist after vaccine was given and mentioned egg allergy told after vaccination pt follow up she was doing good no side effects after vaccination advised to seek er if any side effects , note: no pain or redness or weekness or side effects at the site of injection when contacted the pt ( just on the report have to choose an option ) More
2850318 65 F TX 07/18/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
55th4
Injection site erythema, Injection site pain, Injection site swelling, Product a... Injection site erythema, Injection site pain, Injection site swelling, Product administered at inappropriate site More
Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injec... Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Additional Details: Patient visited doctor after pain/swelling/redness in injection site did not subside. Doctor mentioned that the injection appeared to be given too low on the arm. Redness and swelling are better, but patient is still experiencing pain. More
2850319 79 F KS 07/18/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
TS525
Tachycardia Tachycardia
Systemic: tachycardia-Mild, Systemic: Tachycardia-Mild Systemic: tachycardia-Mild, Systemic: Tachycardia-Mild
2850320 55 F CT 07/18/2025 PNC20
PFIZER\WYETH
LJ5284
Injection site pain Injection site pain
Site: Pain at Injection Site-Medium, Additional Details: Patient reported event via email. Patient ... Site: Pain at Injection Site-Medium, Additional Details: Patient reported event via email. Patient unable to be reached by phone after multiple attempts. More
2850321 34 F FL 07/18/2025 HPV9
MERCK & CO. INC.
y008640
Injection site erythema, Injection site pain, Injection site swelling Injection site erythema, Injection site pain, Injection site swelling
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection... Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Other Vaccines: VaccineTypeBrand: heplisav; Manufacturer: dynavax; LotNumber: 946060; Route: im; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN More
2850322 17 M NV 07/18/2025 MNQ
MNQ
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
57h54
57h54
Dizziness, Eye movement disorder, Injection site erythema, Loss of consciousness... Dizziness, Eye movement disorder, Injection site erythema, Loss of consciousness, Pallor; Syncope, Unresponsive to stimuli, Vomiting More
Site: Redness at Injection Site-Mild, Systemic: Fainting / Unresponsive-Medium, Additional Details: ... Site: Redness at Injection Site-Mild, Systemic: Fainting / Unresponsive-Medium, Additional Details: Immunizer gave Menveo Injection IM Left Arm and after the injection patient said he felt light headed and then his eyes rolled back and he passed out. immunizer Immediately called me over and he regained consciousness once I got there. His face was very pale and threw up. I gave him water and OJ. We called 911. His mom was in the room the whole time EMT took his vitals and said he looked good. After about 20 min or so he felt fine and left with his mom. More
2850323 73 F OH 07/18/2025 TDAP
GLAXOSMITHKLINE BIOLOGICALS
793pt
Injection site bruising, Injection site erythema, Injection site pain, Injection... Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling More
Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injec... Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Other Vaccines: VaccineTypeBrand: Shingles (Shingrix); Manufacturer: GSK; LotNumber: 2M7GR; Route: IM; BodySite: Left Arm; Dose: ; VaxDate: UNKNOWN More
2850324 72 F AZ 07/18/2025 PNC21
MERCK & CO. INC.
y019158
Injection site erythema, Injection site pruritus, Injection site rash, Injection... Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling, Injection site warmth More
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at In... Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Mild, Additional Details: patient present on 7/10 with rash at injection site and is itchy/warm to the touch. recommended pt to try topical ice and hydrocortisone cream. and to let us know if it gets any worse. More
2850325 41 M FL 07/18/2025 HPV9
MERCK & CO. INC.
z002903
Hypoaesthesia, Paraesthesia, Pruritus Hypoaesthesia, Paraesthesia, Pruritus
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Numbness (specify: fa... Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Patient waiting to see if symptoms subside prior to doctor visit if symptoms persist patient will proceed with doctor visit within 72 hours. Will followup with patient in 24 hours from vaccine administration. More
2850326 65 F CA 07/18/2025 RSV
GLAXOSMITHKLINE BIOLOGICALS
xa534
Injection site bruising, Injection site erythema, Injection site pain Injection site bruising, Injection site erythema, Injection site pain
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injec... Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium More
2850327 60 F CA 07/18/2025 PNC21
MERCK & CO. INC.
z003579
Injection site erythema, Injection site pain, Injection site swelling Injection site erythema, Injection site pain, Injection site swelling
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injec... Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Other Vaccines: VaccineTypeBrand: arexvy; Manufacturer: ; LotNumber: xa53y; Route: intramuscular; BodySite: left arm; Dose: 1; VaxDate: 07/07/2025 More
2850328 82 F FL 07/18/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
39h2s
Injection site erythema, Injection site pain, Injection site pruritus, Skin exfo... Injection site erythema, Injection site pain, Injection site pruritus, Skin exfoliation More
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Inject... Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Additional Details: Patient came in on 07/10/2025 at 5:08pm stating the vaccine she had received on 06/20/25 had caused her to have current reddness, injection site pain and peeling of skin around the injection site. Stated when she had the injection on 06/20/25, she had experienced some arm pain and it had continued to worsen. Advised patient to seek medical attention as soon as she can to look at the condition. Patient denied that she is unable to breathe and is able to continue with her daily activities More
2850329 61 F CA 07/18/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
33fd3
Injection site erythema Injection site erythema
Site: Redness at Injection Site-Medium, Additional Details: pt stopped by the pharmacy and complaine... Site: Redness at Injection Site-Medium, Additional Details: pt stopped by the pharmacy and complained of skin redness that developed a day after receiving shingrix vaccine at the pharmacy. Skin redness described as ( 4x6 in) area on the left lateral arm, right beneath her deltoid region where she received the injection. Smooth looking skin with no raised lesions or hives observed at the redness area. Pt said she has been applying ice to the area. Recommended her to take benadryl to control the allergic rxn sx and advised her to go to urgent care More
2850330 16 F GA 07/18/2025 MNQ
NOVARTIS VACCINES AND DIAGNOSTICS
57H54
Seizure Seizure
Systemic: Seizure-Medium, Other Vaccines: VaccineTypeBrand: HPV (GARDASIL 9); Manufacturer: Merck; ... Systemic: Seizure-Medium, Other Vaccines: VaccineTypeBrand: HPV (GARDASIL 9); Manufacturer: Merck; LotNumber: Z005055; Route: IM; BodySite: Right Arm; Dose: 2 of 3; VaxDate: 07/12/2025 More
2850331 29 F KY 07/18/2025 COVID19-2
COVID19-2
PFIZER\BIONTECH
PFIZER\BIONTECH
ME6072
ME6072
Anaphylactic reaction, Cough, Dysphagia, Dyspnoea, Flushing; Hyperhidrosis, Thro... Anaphylactic reaction, Cough, Dysphagia, Dyspnoea, Flushing; Hyperhidrosis, Throat tightness More
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: A... Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Flushed / Sweating-Severe, Additional Details: She began coughing within 5 minutes of the vaccine and started grabbing her throat. By the time I got out to her, she was in extreme distress. More
2850332 54 M OH 07/18/2025 PNC21
PNC21
MERCK & CO. INC.
MERCK & CO. INC.
0175541842
0175541842
Erythema, Headache, Injection site erythema, Injection site pain, Injection site... Erythema, Headache, Injection site erythema, Injection site pain, Injection site pruritus; Injection site swelling, Pain in extremity, Peripheral swelling, Pyrexia More
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Severe, Site: Redness at Inject... Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Fever-Severe, Systemic: Headache-Medium, Additional Details: pain, swelling, redness traveled from injection site down to the hand over a week after the vaccine More
2850333 61 M AL 07/18/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
x5t42
Arthralgia, Injection site pain, Mobility decreased, Pain in extremity Arthralgia, Injection site pain, Mobility decreased, Pain in extremity
Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Severe, Additional Details: patient said h... Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Severe, Additional Details: patient said her arm hurt and she cannot lift it above her shoulder. she does not wantt to go to md since she has high deductible, Other Vaccines: VaccineTypeBrand: boostrix; Manufacturer: ; LotNumber: kr75k; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN More
2850334 76 F FL 07/18/2025 PNC20
PFIZER\WYETH
ln4930
Injection site erythema, Injection site pruritus, Injection site swelling Injection site erythema, Injection site pruritus, Injection site swelling
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Inject... Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: Pt came in on 07/14/25 at 9:05 am and displayed her arm with slight redness and swelling from when she got a prevnar 20 and covid 19 (pfizer) vaccine together on the same day. Pt has gotten a covid vaccine before and suspects it to be from prevnar. Advised pt to seek professional help for check up and pt confirmed no limitations to daily activities, Other Vaccines: VaccineTypeBrand: covid; Manufacturer: pfizer; LotNumber: me6072; Route: intramuscular; BodySite: left deltoid; Dose: ; VaxDate: UNKNOWN More
2850335 4 M MA 07/18/2025 DTAPIPV
MMRV
SANOFI PASTEUR
MERCK & CO. INC.
U8383AB
Z007853
Posture abnormal, Seizure, Tremor; Posture abnormal, Seizure, Tremor Posture abnormal, Seizure, Tremor; Posture abnormal, Seizure, Tremor
Mom was lying next to him in bed and noticed that he was shaking. Mom thought he might be cold and ... Mom was lying next to him in bed and noticed that he was shaking. Mom thought he might be cold and pulled a blanket on him. Lasted 6 seconds in total. Patient was sleeping at naptime later in day and started convulsing. Lasted less than 10 seconds. Legs were extended and upper arms were flexed. Eyes were closed. Did not pick him up or touch him until the shaking stopped. Patient was conversant with them immediately after the episode. By the time mom arrived, patient was in a chair. Seemed a little out of it, but that is normal when he wakes from a nap. More
2850336 14 M ID 07/18/2025 HPV9
MENB
MNQ
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
SANOFI PASTEUR
Y007991
G334J
U8438AA
Inappropriate schedule of product administration; Inappropriate schedule of prod... Inappropriate schedule of product administration; Inappropriate schedule of product administration; Inappropriate schedule of product administration More
Patient given Men A and Men B too early. Parents notified that patient will need imms again at late... Patient given Men A and Men B too early. Parents notified that patient will need imms again at later date. More
2850337 F TX 07/18/2025 COVID19
COVID19
COVID19
COVID19
COVID19
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH





Alanine aminotransferase, Antineutrophil cytoplasmic antibody, Aspartate aminotr... Alanine aminotransferase, Antineutrophil cytoplasmic antibody, Aspartate aminotransferase, Biopsy muscle, Blood bilirubin; Blood creatine phosphokinase, Blood creatine phosphokinase MB, Blood thyroid stimulating hormone, CSF glucose, CSF protein; CSF red blood cell count, CSF test, CSF white blood cell count, Chest X-ray, Glycosylated haemoglobin; HLA marker study, Magnetic resonance imaging spinal, Physical examination, Renal function test, Rhabdomyolysis; Rheumatoid factor, Smooth muscle antibody, Thyroxine free, White blood cell count More
Vaccine-Induced Rhabdomyolysis; This is a literature report . A 53-year-old female patient received... Vaccine-Induced Rhabdomyolysis; This is a literature report . A 53-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The following information was reported: RHABDOMYOLYSIS (caused hospitalization) with onset 2021, 45 days after the suspect product(s) administration, outcome "recovered", described as "Vaccine-Induced Rhabdomyolysis". The patient was hospitalized and prolonged hospitalization for rhabdomyolysis (hospitalization duration: 43 day(s)). The patient's medical history, historical vaccinations, concomitant medications, and clinical course was reported as follows: The patient initially presented to the hospital after 3 weeks of progressive proximal extremity weakness. The patient reported bilateral proximal upper and lower extremities pain, which started with the left lower extremity and progressed to the right lower extremity. One week later, the patient reported right upper extremity pain followed by left extremity pain. She noted a decrease in exercise capacity, from 30 minutes on the treadmill to 10-15 minutes. She denied prior similar symptoms. The pain was described as muscle soreness from a workout that occurred predominantly with movement. Neck and lower back pain were endorsed but the patient attributed these findings to a sedentary job. The patient received the second dose of COVID-19 vaccine (Pfizer-BioNTech COVID-19 Vaccine), in early 2021, with both vaccines given in the left arm. Adverse effects reported from the vaccine included nausea and vomiting that resolved after 2 weeks. Presentation of symptoms occurred about 45 days after the second dose. The patient denied fever, chills, headache, recent trauma, shortness of breath, recent upper respiratory infections, gastrointestinal infections, pain in extremities, chest pain, rashes, recent travels, camping, new diet/foods (honey), medication changes, family history or cancers personally or in family. The patient had a past medical history of diabetes mellitus and dyslipidemia. Medications included atorvastatin 80 mg which was decreased to 40 mg, due to left extremity soreness, about 45 days after the second dose, and metformin 500 mg. Of note, the patient had been on atorvastatin for over 3 years. Surgical history included ectopic pregnancy status post laparoscopy. She had no known drug allergies. The patient reported she consumed alcoholic beverages on occasion but denied smoking or recreational drug use. Physical exam showed the patient had bilateral proximal weakness in the upper and lower extremities, which was specifically pronounced bilaterally in the thighs. She was also noted to have pronounced tenderness on passive and active movements of bilateral upper and lower extremities. Initial labs included creatine kinase of 7800 U/L initially, which trended down during hospitalization. Other labs included, aspartate aminotransferase 241 U/L, alanine aminotransferase 384 U/L, total bilirubin 1.2 mg/ dL, white blood cell (WBC) count 10.4 x 109/L , thyroid-stimulating hormone 7.18 uUI/mL with free T4 1.15 ng/dL, creatine kinase MB 292.3 U/L, HbA1c 6.3%, rheumatoid factor less than 10 IU/ mL, cytoplasmic anti-neutrophil cytoplasmic antibody less than 0.2 IU/mL, and anti-smooth muscle antibody of 14 units. Cerebrospinal fluid (CSF) analysis was obtained, which showed colorless fluid with CSF protein of 24.7 mg/dl, CSF WBC 0 x 109/L, CSF RBC 1, CSF glucose 66 mg/ dL. The CSF results were not consistent with Guillain-Barre syndrome. Imaging consisted of chest x-ray which demonstrated no abnormalities. A magnetic resonance image without contrast of cervical spine/ lumbar spine/extremities demonstrated mild degenerative changes in the discs throughout the region with mild diffuse annular disc bulging and spondylosis at C5-6 and C6-7. Lumbar region findings included mild degenerative changes in discs, otherwise, with no other acute abnormality. Extremities were noted to have no significant abnormality. A right thigh skeletal muscle biopsy was ordered, which was consistent with necrotizing myopathy, without specific diagnostic features and without features of chronic myopathic disorder. HLA class I immunohistochemistry was negative which provided support for nonimmune myopathy. Atorvastatin was discontinued on day 1 of hospitalization. The patient received aggressive intravenous hydration consisting of normal saline at 150 cc/hr, increased to 200 cc/hr on day 2 of hospitalization, and sustained at 200 cc/hr until day 41. Kidney function was monitored throughout the hospitalization and reοΏ½mained within normal limits. Strict intake and output were documented along with volume status evaluation. The patient also received prednisone from day 1 to day 42 of hospitalization (30-40 mg PO daily) due to suspicion of an autoimmune process. She was also given intra-venous immunoglobulin from day 37 to day 42 and was monitored for possible improvement in creatine kinase. The patient symptomatically improved throughout the hospitalization and was discharged home on Day 43 with close follow-up. Therapeutic measures were taken as a result of rhabdomyolysis. Per the author's discussion: There are few published cases of similar symptoms with COVID-19 vaccine. Unlike prior similar cases, our patient demonstrated a delayed adverse effect, approximately 5 weeks after injection of the second vaccine dose. This could be attributed to the efficacy of the second dose of vaccine with age, cellular, and humoral immune responses as contributing factors, with studies demonstrating peak IgA/ IgG approximately 5 weeks. Rhabdomyolysis secondary to vaccines has been previously described with the influenza vaccine. These cases displayed similar histopathological features on biopsy as our patient: a small number of lymphocytes, almost exclusively associated with necrotic and regenerating myofibers; minimal inflammation, with negative HLA Class I immunohistochemistry, supporting a non-immune (non-inflammatory) myopathy.; Sender's Comments: A possible contributory role of the suspect products cannot be excluded for the reported event Rhabdomyolysis. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators as appropriate. More
βœ“
2850338 52 F PA 07/18/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
3273H
Back pain, Injection site pain, Muscle spasms, Pain in extremity Back pain, Injection site pain, Muscle spasms, Pain in extremity
Soreness at the injection site, lower back spasms, and pain on the left side from lower back to leg. Soreness at the injection site, lower back spasms, and pain on the left side from lower back to leg.
2850339 48 F GA 07/18/2025 TDAP
GLAXOSMITHKLINE BIOLOGICALS
EB499
Pain, Pain in extremity Pain, Pain in extremity
Patient was treated in our office due to a needlestick. She received a TDAP vaccine at that time. A ... Patient was treated in our office due to a needlestick. She received a TDAP vaccine at that time. A few days following the event patient began to have extreme pain from her upper arm to mainly just below her elbow. She reports the pain as pulsating. She reports difficulty describing the pain as it can almost feel numb at times. We have recommended cold compress and OTC pain medications More
2850340 0.67 F VA 07/18/2025 DTAPIPV
GLAXOSMITHKLINE BIOLOGICALS
YN2x2
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
An 8-month-old patient was brought in by the mother for routine vaccinations. The mother prefers to ... An 8-month-old patient was brought in by the mother for routine vaccinations. The mother prefers to space out vaccines. To accommodate the parent s request, Kinrix a combination vaccine for DTaP and IPV was chosen instead of administering two separate shots. Kinrix is specifically for ages 4 years and older. This age-related description was not discussed with the parent during the visit. The parent was not informed that Kinrix, a vaccine intended for older children, was being administered. No adverse reactions reported or occurred. More
2850341 53 M MN 07/18/2025 COVID19
MODERNA
021C21A
Burning sensation, Fatigue, Nervous system disorder, Tinnitus Burning sensation, Fatigue, Nervous system disorder, Tinnitus
Fatigue, tinnitus, burning sensations, other nervous system events, Fatigue, tinnitus, burning sensations, other nervous system events,
2850343 28 F WY 07/18/2025 TDAP
SANOFI PASTEUR
3CA34C1
Contusion, Pain, X-ray normal Contusion, Pain, X-ray normal
Around 10 days following the injection, patient noted bruising, worsening pain, and increasing pain ... Around 10 days following the injection, patient noted bruising, worsening pain, and increasing pain with push/pull motions More
2850344 88 F MN 07/18/2025 MMR
PNC20
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
GE974
LX4483
GJ952
Dizziness, Dysstasia; Dizziness, Dysstasia; Dizziness, Dysstasia Dizziness, Dysstasia; Dizziness, Dysstasia; Dizziness, Dysstasia
Patient started feeling very dizzy about 15 minutes post immunizations. He couldn't stand and ... Patient started feeling very dizzy about 15 minutes post immunizations. He couldn't stand and had to put his head between his legs. He eventually felt well enough to drive. He refused an ambulance. More
2850345 40 F ID 07/18/2025 TDAP
TDAP
TDAP
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
U8353BA
U8353BA
U8353BA
Abdominal distension, Axillary pain, Chills, Dizziness, Erythema; Fatigue, Flush... Abdominal distension, Axillary pain, Chills, Dizziness, Erythema; Fatigue, Flushing, Headache, Injection site mass, Injection site pain; Injection site warmth, Myalgia, Nausea, Pain, Palpitations More
Today she states overall feeling a bit worse than date of injury. States on 7/15 localized symptoms ... Today she states overall feeling a bit worse than date of injury. States on 7/15 localized symptoms started and towards the end of the night she began to have muscle soreness, fatigue. The following day she developed more soreness, body aches/chills, facial flushing, and a hard lump at the injection site. The following day, 7/17 she developed deep, burning pain into her axilla, nausea, increased erythema, the injection site became hot, tender to touch, fatigue and headaches, dizziness, palpations, epigastric fullness. Today she woke with worsening pain at the injection site, worsening fatigue, headache, body aches. Does endorse the epigastric fullness, palpitations, dizziness are resolved now. States touch is painful, clothing rubbing on the injection site is painful and continues to be warm and tender to touch. Current treatments: - Benadryl - Hydrocortisone cream - Tylenol - Pepcid - Zyrtec - Ice - Tramadol - Zofran - Anti-Inflammatories More
2850346 11 F CA 07/18/2025 COVID19
HPV9
MNQ
TDAP
PFIZER\BIONTECH
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
GLAXOSMITHKLINE BIOLOGICALS
LN7302
Y015179
3E99M
L5229
Product storage error; Product storage error; Product storage error; Product sto... Product storage error; Product storage error; Product storage error; Product storage error More
Covid vaccine was administered outside the recommended 10 weeks after taken from the ultra cold env... Covid vaccine was administered outside the recommended 10 weeks after taken from the ultra cold environment. More
2850347 6 F CA 07/18/2025 COVID19
FLU3
PFIZER\BIONTECH
GLAXOSMITHKLINE BIOLOGICALS
LN7302
CZ47E
Product storage error; Product storage error Product storage error; Product storage error
Covid vaccine was administered outside the recommended 10 weeks after taken from the ultra cold env... Covid vaccine was administered outside the recommended 10 weeks after taken from the ultra cold environment. More
2850348 8 F MO 07/18/2025 DTAPIPV
MMRV
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
4L454
Z003308
Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered
Patient had received all recommended doses of these vaccinations. These additional doses were admini... Patient had received all recommended doses of these vaccinations. These additional doses were administered in error. Discussed with parents. Advised of possible side effects of sore arm, fever, pain and rash at the injection site. Discussed interventions such as administration of acetaminophen or ibuprofen for pain or fever, apply cold compress as needed. Consult physician if child develops more severe or prolonged symptoms. More
2850349 12 F 07/18/2025 COVID19
TYP
PFIZER\BIONTECH
SANOFI PASTEUR
ME6072
Y2A031M
Laboratory test, Palpitations; Laboratory test, Palpitations Laboratory test, Palpitations; Laboratory test, Palpitations
Per patient's mother, patient had gone to the ER the night of 7/17/25 due to palpitations. Base... Per patient's mother, patient had gone to the ER the night of 7/17/25 due to palpitations. Based on the encounter, the medical staff had run tests and sent the patient home with instructions to continue monitoring heartrate. More
2850350 78 F CA 07/18/2025 COVID19
PNC20
PFIZER\BIONTECH
PFIZER\WYETH
ME6072
LN4929
Dizziness, Dizziness postural, Headache, Rash erythematous, Rash pruritic; Dizzi... Dizziness, Dizziness postural, Headache, Rash erythematous, Rash pruritic; Dizziness, Dizziness postural, Headache, Rash erythematous, Rash pruritic More
Patient came to pharmacy 7/18/25 @ 09:20 reporting a left-arm circumferential pink rash 3 inches bel... Patient came to pharmacy 7/18/25 @ 09:20 reporting a left-arm circumferential pink rash 3 inches below vaccination site (and 1 inch above elbow bend). States it started the morning after injection of both Prevnar 20 and Comirnaty. Patient states she felt dizzy spells and tingles in her head at night with some headache. She also reported mild orthostasis/dizziness upon rising from a reclined or lying position. She says the rash it a little itchy. I recommended she speak to her MD immediately (she states she did and has an appointment this Monday, 7/21/25). I recommended some 1% hydrocortisone to help reduce the pinkness and itchiness from the rash and to report to her MD immediately if her dizzy spells continue. I advised her not to drive (she did drive to the pharmacy today to report her adverse events). More
2850351 17 F TN 07/18/2025 MENB
PFIZER\WYETH
LW8911
Pharyngeal swelling, Swelling face, Throat irritation, Urticaria Pharyngeal swelling, Swelling face, Throat irritation, Urticaria
Two days following immunization she developed facial swelling, hives, throat itching/swelling. No ot... Two days following immunization she developed facial swelling, hives, throat itching/swelling. No other symptoms of illness and no medications taken in the last month. More
2850352 0.5 M FL 07/18/2025 DTAPIPVHIB
PNC20
RV5
SANOFI PASTEUR
PFIZER\WYETH
MERCK & CO. INC.
UK194AA
LK6655
Y015019
Drooling, Lip swelling, Pyrexia; Drooling, Lip swelling, Pyrexia; Drooling, Lip ... Drooling, Lip swelling, Pyrexia; Drooling, Lip swelling, Pyrexia; Drooling, Lip swelling, Pyrexia More
The morning after receiving vaccinations, patient presented to the ED for swelling of the lower lip,... The morning after receiving vaccinations, patient presented to the ED for swelling of the lower lip, mild drooling, and fever. Patient was observed at ED without any increase in swelling or evidence of angioedema or anaphylaxis. More
2850353 07/18/2025 COVID19
PFIZER\BIONTECH

Death Death
took the Pfizer vaccine and passed away after it; This is a spontaneous report received from a Consu... took the Pfizer vaccine and passed away after it; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOD-2025-788038 (Moderna). A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "took the Pfizer vaccine and passed away after it". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Clinical course: Caller stated knew of a that took the Pfizer vaccine and passed away after it. It is unknown if the patient experienced any additional symptoms/events. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.; Reported Cause(s) of Death: unknown cause of death More
βœ“